Protocol A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir [Paxlovid] in Adults With Long COVID, 2023, Iwasaki el al.
Discussion in 'Long Covid research' started by Jaybee00, Mar 22, 2023.
Discussion in 'Long Covid research' started by Jaybee00, Mar 22, 2023.